|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.92 USD | -0.31% |
|
+2.20% | +2.02% |
| 05/01 | Wells Fargo Cuts Price Target on Mondelez International to $62 From $72, Maintains Overweight Rating | MT |
| 31/12 | Sector Update: Consumer Stocks Decline in Afternoon Trading | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.06 | 4.63 | 4.41 | 5.24 | 5.76 | |||||
Return on Total Capital | 5.64 | 6.45 | 6.16 | 7.54 | 8.57 | |||||
Return On Equity % | 12.98 | 15.41 | 9.87 | 17.97 | 16.71 | |||||
Return on Common Equity | 12.97 | 15.4 | 9.85 | 17.96 | 16.69 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 39.3 | 39.19 | 36.06 | 38.22 | 39.12 | |||||
SG&A Margin | 22.41 | 21.33 | 20.16 | 21.22 | 21.03 | |||||
EBITDA Margin % | 20.36 | 21.26 | 18.99 | 19.95 | 21.25 | |||||
EBITA Margin % | 16.89 | 17.86 | 15.9 | 17 | 18.1 | |||||
EBIT Margin % | 16.16 | 17.39 | 15.48 | 16.58 | 17.68 | |||||
Income From Continuing Operations Margin % | 13.43 | 15.02 | 8.66 | 13.79 | 12.69 | |||||
Net Income Margin % | 13.37 | 14.97 | 8.63 | 13.77 | 12.65 | |||||
Net Avail. For Common Margin % | 13.37 | 14.97 | 8.63 | 13.77 | 12.65 | |||||
Normalized Net Income Margin | 10.07 | 11.02 | 9.85 | 10.1 | 11.01 | |||||
Levered Free Cash Flow Margin | 14.44 | 8.38 | 11.89 | 12.11 | 7.53 | |||||
Unlevered Free Cash Flow Margin | 15.65 | 9.15 | 12.72 | 13.05 | 8.38 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.4 | 0.43 | 0.46 | 0.51 | 0.52 | |||||
Fixed Assets Turnover | 2.8 | 3.03 | 3.32 | 3.59 | 3.53 | |||||
Receivables Turnover (Average Receivables) | 11.79 | 12.4 | 11.61 | 10.72 | 9.71 | |||||
Inventory Turnover (Average Inventory) | 6.21 | 6.52 | 6.62 | 6.36 | 5.96 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.66 | 0.74 | 0.6 | 0.62 | 0.68 | |||||
Quick Ratio | 0.43 | 0.48 | 0.35 | 0.33 | 0.32 | |||||
Operating Cash Flow to Current Liabilities | 0.26 | 0.3 | 0.23 | 0.25 | 0.25 | |||||
Days Sales Outstanding (Average Receivables) | 31.04 | 29.45 | 31.43 | 34.06 | 37.7 | |||||
Days Outstanding Inventory (Average Inventory) | 58.9 | 55.95 | 55.18 | 57.38 | 61.39 | |||||
Average Days Payable Outstanding | 135.95 | 134.73 | 125.32 | 128.91 | 145.07 | |||||
Cash Conversion Cycle (Average Days) | -46.01 | -49.33 | -38.71 | -37.47 | -45.98 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 76.1 | 71.13 | 87.72 | 70.89 | 68.79 | |||||
Total Debt / Total Capital | 43.22 | 41.56 | 46.73 | 41.48 | 40.75 | |||||
LT Debt/Equity | 64.17 | 63.58 | 77.14 | 61.43 | 60.42 | |||||
Long-Term Debt / Total Capital | 36.44 | 37.16 | 41.09 | 35.94 | 35.79 | |||||
Total Liabilities / Total Assets | 59.22 | 57.78 | 62.17 | 60.27 | 60.64 | |||||
EBIT / Interest Expense | 8.34 | 14.11 | 11.69 | 11.06 | 12.94 | |||||
EBITDA / Interest Expense | 11.86 | 19.39 | 16.32 | 15.15 | 17.32 | |||||
(EBITDA - Capex) / Interest Expense | 10.19 | 16.66 | 14.14 | 13.09 | 14.54 | |||||
Total Debt / EBITDA | 3.45 | 2.93 | 3.47 | 2.46 | 2.15 | |||||
Net Debt / EBITDA | 2.85 | 2.42 | 3.19 | 2.24 | 1.99 | |||||
Total Debt / (EBITDA - Capex) | 4.01 | 3.41 | 4 | 2.84 | 2.56 | |||||
Net Debt / (EBITDA - Capex) | 3.32 | 2.81 | 3.68 | 2.59 | 2.37 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 2.76 | 8.05 | 9.67 | 14.35 | 1.18 | |||||
Gross Profit, 1 Yr. Growth % | 1.05 | 7.74 | 0.91 | 21.68 | 3.58 | |||||
EBITDA, 1 Yr. Growth % | 5.41 | 12.76 | -2.05 | 23.09 | 7.76 | |||||
EBITA, 1 Yr. Growth % | 5.37 | 14.11 | -2.36 | 25.89 | 7.73 | |||||
EBIT, 1 Yr. Growth % | 5.11 | 16.14 | -2.38 | 26.21 | 7.89 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -9.51 | 20.87 | -36.81 | 82.24 | -6.94 | |||||
Net Income, 1 Yr. Growth % | -9.52 | 20.96 | -36.81 | 82.52 | -7.02 | |||||
Normalized Net Income, 1 Yr. Growth % | 3.95 | 18.17 | -2.03 | 20.73 | 10.37 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -8.18 | 23.08 | -35.53 | 84.69 | -5.52 | |||||
Accounts Receivable, 1 Yr. Growth % | 3.84 | 1.74 | 32.14 | 17.68 | 6.6 | |||||
Inventory, 1 Yr. Growth % | 3.97 | 2.3 | 24.85 | 6.92 | 5.86 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.9 | -4.07 | 4.41 | 7.2 | -1.24 | |||||
Total Assets, 1 Yr. Growth % | 5.11 | -1.06 | 6.06 | 0.32 | -4.05 | |||||
Tangible Book Value, 1 Yr. Growth % | 10.68 | -6.24 | 35.64 | -5.39 | -3.03 | |||||
Common Equity, 1 Yr. Growth % | 1.24 | 2.51 | -4.9 | 5.39 | -4.94 | |||||
Cash From Operations, 1 Yr. Growth % | -0.03 | 4.47 | -5.63 | 20.62 | 4.16 | |||||
Capital Expenditures, 1 Yr. Growth % | -6.7 | 11.82 | -6.11 | 22.74 | 24.73 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 36.73 | -42.28 | 55.7 | 19.31 | -37.1 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 31.17 | -41.49 | 52.51 | 19.99 | -34.99 | |||||
Dividend Per Share, 1 Yr. Growth % | 10.09 | 10.83 | 10.53 | 10.2 | 10.49 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.23 | 5.37 | 8.85 | 11.98 | 7.56 | |||||
Gross Profit, 2 Yr. CAGR % | 0.45 | 4.34 | 4.26 | 10.59 | 12.26 | |||||
EBITDA, 2 Yr. CAGR % | 8.75 | 9.07 | 5.1 | 8.48 | 15.17 | |||||
EBITA, 2 Yr. CAGR % | 6.74 | 9.7 | 5.55 | 9.26 | 16.45 | |||||
EBIT, 2 Yr. CAGR % | 6.82 | 10.54 | 6.48 | 9.35 | 16.69 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.51 | 4.59 | -12.6 | 7.31 | 30.23 | |||||
Net Income, 2 Yr. CAGR % | 3.53 | 4.61 | -12.58 | 7.39 | 30.27 | |||||
Normalized Net Income, 2 Yr. CAGR % | 5.38 | 10.88 | 7.6 | 7.17 | 15.43 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 5.24 | 6.31 | -10.92 | 9.12 | 32.09 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.77 | 2.79 | 15.95 | 24.7 | 12.01 | |||||
Inventory, 2 Yr. CAGR % | 1.06 | 3.13 | 13.02 | 15.54 | 6.39 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.74 | -0.16 | 0.08 | 5.8 | 2.89 | |||||
Total Assets, 2 Yr. CAGR % | 3.97 | 1.98 | 2.44 | 3.15 | -1.89 | |||||
Tangible Book Value, 2 Yr. CAGR % | -1.12 | 1.87 | 12.77 | 13.28 | -4.22 | |||||
Common Equity, 2 Yr. CAGR % | 3.72 | 1.87 | -1.27 | 0.11 | 0.09 | |||||
Cash From Operations, 2 Yr. CAGR % | 0.2 | 2.2 | -0.71 | 6.69 | 12.09 | |||||
Capital Expenditures, 2 Yr. CAGR % | -11.22 | 2.14 | 2.46 | 7.35 | 23.73 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 34.89 | -7.42 | -5.2 | 34.65 | -13.37 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 31.98 | -8.98 | -5.54 | 33.75 | -11.68 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.8 | 10.46 | 10.68 | 10.37 | 10.35 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 0.87 | 3.45 | 6.78 | 10.66 | 8.26 | |||||
Gross Profit, 3 Yr. CAGR % | 1.35 | 2.82 | 3.18 | 9.63 | 8.2 | |||||
EBITDA, 3 Yr. CAGR % | 5.83 | 10.1 | 5.23 | 9.88 | 8.24 | |||||
EBITA, 3 Yr. CAGR % | 4.56 | 9.17 | 5.52 | 10.85 | 8.75 | |||||
EBIT, 3 Yr. CAGR % | 4.64 | 9.87 | 6.05 | 11.56 | 8.86 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 7.89 | 9 | -11.58 | 11.66 | 2.33 | |||||
Net Income, 3 Yr. CAGR % | 7.92 | 9.04 | -11.57 | 11.73 | 2.35 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.67 | 9.52 | 6.4 | 10.72 | 8.22 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 10.11 | 10.88 | -10.02 | 13.59 | 4 | |||||
Accounts Receivable, 3 Yr. CAGR % | -5.14 | 1.09 | 11.76 | 16.52 | 18.35 | |||||
Inventory, 3 Yr. CAGR % | 1.16 | 1.47 | 9.92 | 10.95 | 12.22 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 3.66 | 3.01 | 1.34 | 2.4 | 3.4 | |||||
Total Assets, 3 Yr. CAGR % | 2.51 | 2.27 | 3.32 | 1.73 | 0.69 | |||||
Tangible Book Value, 3 Yr. CAGR % | -2.31 | -2.86 | 12.07 | 6.36 | 7.56 | |||||
Common Equity, 3 Yr. CAGR % | 1.99 | 3.31 | -0.44 | 0.9 | -1.6 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.2 | 1.6 | -0.48 | 5.95 | 5.84 | |||||
Capital Expenditures, 3 Yr. CAGR % | -5.23 | -4.13 | -0.69 | 8.82 | 12.85 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 22.14 | 4.48 | 10.1 | 1.53 | 4.48 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 20.9 | 3.23 | 8.11 | 1.53 | 5.16 | |||||
Dividend Per Share, 3 Yr. CAGR % | 13.53 | 11.48 | 10.48 | 10.52 | 10.41 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -2.15 | 2.07 | 3.99 | 6.79 | 7.09 | |||||
Gross Profit, 5 Yr. CAGR % | -1.92 | 2.18 | 2.51 | 5.86 | 6.64 | |||||
EBITDA, 5 Yr. CAGR % | 3.02 | 7.68 | 5.55 | 9.45 | 8.57 | |||||
EBITA, 5 Yr. CAGR % | 2.59 | 7.5 | 4.97 | 9.21 | 9.13 | |||||
EBIT, 5 Yr. CAGR % | 2.65 | 8.02 | 5.39 | 9.66 | 9.53 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -13.31 | 21.27 | -0.83 | 8.32 | 3.23 | |||||
Net Income, 5 Yr. CAGR % | -13.32 | 21.34 | -0.8 | 8.38 | 3.25 | |||||
Normalized Net Income, 5 Yr. CAGR % | 7.13 | 11.39 | 6.46 | 8.57 | 9.28 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -11.07 | 23.93 | 1.16 | 10.17 | 4.92 | |||||
Accounts Receivable, 5 Yr. CAGR % | -2.7 | -2.19 | 2.79 | 9.95 | 11.86 | |||||
Inventory, 5 Yr. CAGR % | 0.29 | 1.87 | 5.75 | 6.88 | 8.49 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.94 | 2.41 | 2.21 | 4.12 | 1.96 | |||||
Total Assets, 5 Yr. CAGR % | 1.53 | 1.74 | 2.48 | 2.62 | 1.2 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.31 | -1.91 | 3.46 | 3.3 | 5.25 | |||||
Common Equity, 5 Yr. CAGR % | -0.31 | 2.36 | 0.67 | 2.02 | -0.23 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.24 | 7.85 | 8.55 | 3.61 | 4.37 | |||||
Capital Expenditures, 5 Yr. CAGR % | -10.63 | -4.64 | -2.23 | 0.31 | 8.44 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 2.52 | 0.83 | 12.21 | 15.64 | -0.45 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.87 | -0.48 | 11.23 | 14.5 | -0.74 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.4 | 13.06 | 12.38 | 11.03 | 10.43 |
- Stock Market
- Equities
- MDLZ Stock
- Financials Mondelez International, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















